Nextphase Clinical Trials - FL Miami-Dade, Miami Beach 33140

Nextphase Clinical Trials entered the industry of Health Practitioners in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 6214930, which describes it as a Health Practitioners. For further clarification, the SIC classifies this business under the code 8049 and described it as a Health Practitioners. The business provides service to the B2B market.

To acquire more information, please contact Lourdes Gonzalez by calling (305) 397-8679 during business hours. You can also write to the business’ Single Location at 333 West 41st St # 410, Miami Beach, Florida FL 33140. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Nextphase Clinical Trials
Representative: Lourdes Gonzalez
Place of Business: 333 West 41st St # 410, Miami Beach, FL 33140
Contact Number: (305) 397-8679
Type of Service: Health Practitioners
SIC Number: 8049
NAICS Number: 6214930
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2010
Income/Year: $1.000.000 to $2.499.999
Laborers: 1 to 4
Share This Company:

Nextphase Clinical Trials is a company operating from Miami-Dade, Florida providing professional Health Practitioners and relevant B2B variables. It was founded in 2010 and registered with the SIC code 8049 as Health Practitioners, and with the NAICS code 6214930 as Health Practitioners.

With a current employee count of 1 to 4, Nextphase Clinical Trials has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Lourdes Gonzalez at (305) 397-8679 for related queries, or to locate its Single Location using the coordinates 25.81382,-80.12723.

The Single Location can also be found at the street address 333 West 41st St # 410 in Miami Beach, Florida 33140 and can be engaged online through the company website at , the company Twitter , and Facebook page .